Catalyst Wire Dossier Catalyst Wire Dossier

BMN 270

· BioMarin Pharmaceutical
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BMN 270, covering 2026-01-12 to 2026-01-12. Get the full timeline:

Most recent: Clinical Trial Update: A Long-Term Follow-Up Study in Severe Hemophilia A Subjects Who Received BMN 270 in a Prior BioMarin Clinical Trial (270-401)

See pricing